Thomas McNerney & Partners LLC 13D and 13G filings for Clarus Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-21 8:43 pm Sale | 2022-04-20 | 13D | Clarus Therapeutics Holdings, Inc. CRXTQ | Thomas McNerney & Partners LLC | 45,659 0.200% | -5,452,912 (-99.17%) | Filing |
| 2021-12-10 5:01 pm Purchase | 2021-09-09 | 13D | Clarus Therapeutics Holdings, Inc. CRXTQ | Thomas McNerney & Partners LLC | 5,498,571 25.300% | 5,498,571 (New Position) | Filing |